Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase. Can Dermatol Today [Internet]. 25 sept. 2026 [cité 28 sept. 2026];7(3):4-10. Disponible à: https://canadiandermatologytoday.com/article/view/7-3-Netchiporouk_et_al